Atipamezole hydrochloride

SKU: orb1227078

Description

Antipamezole (MPV-1248) is a potent, specific α2-adrenoceptor antagonist with Ki of 1.6 nM; reverses the effects of the sedative dexmedetomidine and medetomidine as a veterinary drug.Alcoholism Phase 1 Discontinued(In Vitro):The affinity of atipamezole for α2-adrenoceptors and its α2/α1 selectivity ratio are considerably higher than yohimbine. Atipamezole is not selective for subtypes of α2-adrenoceptors. It has negligible affinity for 5-HT1, 5-HT2 and I2 bindings sites.\n(In Vivo):Atipamezole is well tolerated in rodents. In anesthetized, normotensive rats, the cardiovascular effects of atipamezole (0.01–1 mg/kg, i.v.) are rather modest. Atipamezole is commonly used by veterinarians to awaken animals from sedation or anesthesia. Atipamezole increases sexual activity in rats and monkeys. In animals with sustained nociception, atipamezole increases pain-related responses by blocking the noradrenergic feedback inhibition of pain. Atipamezole at low doses has beneficial effects on alertness, selective attention, planning, learning, and recall in experimental animals, but not necessarily on short-term working memory.

Key Properties

• CAS Number: 104075-48-1
• MW: 248.7512
• Purity: >98% (HPLC)
• Formula: C₁₄H₁₇ClN₂
• SMILES: CCC1(CC2=CC=CC=C2C1)C3=CN=CN3.Cl
• Target: Adrenergic Receptor
• Solubility: DMSO: ≥ 47 mg/mL

Storage & Handling

• Storage: Storage temperature: -20°C. Stability: ≥ 2 years
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

MPV-1248 hydrochloride | MPV1248 hydrochloride

Quick Database Links

Gene Symbol

Adrenergic Receptor